Table 1 Demographic and clinical characteristics

From: Safety and efficacy of n-3 fatty acid-based parenteral nutrition in patients with obstructive jaundice: a propensity-matched study

Characteristic pre-operation

Before matched

After matched

N-3 fatty group (n = 106)

Control group (n = 120)

P-value

N-3 fatty group (n = 54)

Control group (n = 54)

P-value

Age (years)

58.1 ± 11.2

55.7 ± 12

0.213

56.9 ± 12.4

57.4 ± 11.3

0.846

Male sex No. (%)

36(15.9)

70(31)

0.889

62(58.4)

86(71.7)

0.244

BMI (kg/m2)

21.3 ± 2.7

22.1 ± 2.9

0.027

21.7 ± 2.7

21.7 ± 3

0.933

MNA

7.7 ± 1.1

7.5 ± 0.9

<0.001

4.1 ± 0.9

3.9 ± 1

0.253

NRI

90.9 ± 10.8

91.7 ± 10.7

0.694

91.2 ± 7.5

90.4 ± 11.3

0.672

Child-Pugh score(%)

  

0.154

  

1

6–7

8(6.6)

6(5.6)

 

2(3.7)

2(3.7)

 

8–10

108(90)

100(94.4)

 

52(96.3)

52(96.3)

 

>10

4(3.4)

0(0)

 

0(0)

0(0)

 

Weight loss (kg)a

4.08 ± 3.65

2.76 ± 3.10

0.26

2.8 ± 3

3.1 ± 3.6

0.567

WBC ( × 10^9 / L)

7.97 ± 4.4

6.73 ± 2.87

0.015

7.48 ± 3.91

7.32 ± 3.14

0.821

ALT(U/L)

147 ± 150

104 ± 109

0.017

103 ± 87

114 ± 109

0.549

AST(U/L)

129 ± 129

106 ± 81

<0.001

77 ± 42

91 ± 62

0.176

TP(g/L)

64 ± 8.3

64 ± 5.7

0.46

63.1 ± 7.1

64.3 ± 6

0.352

ALB(g/L)

34.7 ± 6.7

34.2 ± 5.4

0.587

33.8 ± 4.5

33.6 ± 4.3

0.846

PALB (mg/L)

117 ± 56

123 ± 38

0.366

115 ± 48

116 ± 41

0.905

TBIL (µmol/L)

197.2 ± 170.4

192 ± 111.5

0.788

176.1 ± 147.8

179.8 ± 118.8

0.886

DBIL(µmol/L)

158.8 ± 103.1

149.2 ± 123.8

0.524

151.5 ± 109.6

161.3 ± 127.3

0.669

BUN(µmol/L)

4.48 ± 2.23

4.3 ± 2.12

0.535

4.4 ± 2.2

4.1 ± 2.3

0.462

UA(μmol/L)

177.8 ± 72.7

170.4 ± 66.4

0.434

180 ± 62

180 ± 72

0.984

  1. Data are means ± standard deviations or number (%) unless otherwise indicated
  2. aWeight loss = usual weight−weight on inclusion